Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
$0.20
$0.17
$2.96
$13M-25.93N/AN/A
Jushi Holdings Inc. stock logo
JUSHF
Jushi
$0.29
-3.2%
$0.32
$0.22
$0.69
$57.02M-1.1857,538 shs38,415 shs
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
$14.49
-6.8%
$18.53
$12.12
$26.99
$46.22M0.5923,474 shs52,234 shs
Zomedica Corp. stock logo
ZOMDF
Zomedica
$0.04
-0.7%
$0.05
$0.02
$0.17
$39.69M1.564.86 million shs2.61 million shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
0.00%0.00%0.00%0.00%-82.29%
Jushi Holdings Inc. stock logo
JUSHF
Jushi
0.00%+5.07%-0.82%-0.28%-48.03%
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
0.00%-6.85%-8.24%-16.34%-17.95%
Zomedica Corp. stock logo
ZOMDF
Zomedica
0.00%-2.41%-15.63%-30.17%-72.30%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
N/AN/AN/AN/AN/AN/AN/AN/A
Jushi Holdings Inc. stock logo
JUSHF
Jushi
1.1255 of 5 stars
0.04.00.00.02.11.70.6
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
2.0373 of 5 stars
3.54.00.00.02.00.00.0
Zomedica Corp. stock logo
ZOMDF
Zomedica
0.3113 of 5 stars
0.05.00.00.00.60.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
0.00
N/AN/AN/A
Jushi Holdings Inc. stock logo
JUSHF
Jushi
1.50
ReduceN/AN/A
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
3.00
Buy$35.50145.00% Upside
Zomedica Corp. stock logo
ZOMDF
Zomedica
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest CHHE, JUSHF, VTVT, and ZOMDF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/9/2025
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$36.00
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
$110K0.00N/AN/A$0.60 per share0.00
Jushi Holdings Inc. stock logo
JUSHF
Jushi
$257.52M0.22N/AN/A($0.26) per share-1.12
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
$1.02M45.32N/AN/A$4.48 per share3.23
Zomedica Corp. stock logo
ZOMDF
Zomedica
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
-$410K-$0.020.00N/AN/AN/AN/AN/AN/A
Jushi Holdings Inc. stock logo
JUSHF
Jushi
-$48.78M-$0.24N/AN/AN/A-18.54%N/A-10.71%8/6/2025 (Estimated)
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
-$18.46M-$3.01N/AN/AN/A-121.46%-46.75%8/6/2025 (Estimated)
Zomedica Corp. stock logo
ZOMDF
Zomedica
N/A-$0.11N/AN/AN/AN/AN/AN/A

Latest CHHE, JUSHF, VTVT, and ZOMDF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
-$0.73-$0.77-$0.04-$0.77N/AN/A
5/8/2025Q1 2025
Jushi Holdings Inc. stock logo
JUSHF
Jushi
-$0.06-$0.09-$0.03-$0.09$66.23 million$63.85 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
N/AN/AN/AN/AN/A
Jushi Holdings Inc. stock logo
JUSHF
Jushi
N/AN/AN/AN/AN/A
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
N/AN/AN/AN/AN/A
Zomedica Corp. stock logo
ZOMDF
Zomedica
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
N/AN/AN/A
Jushi Holdings Inc. stock logo
JUSHF
Jushi
N/A
1.13
0.57
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
N/A
7.39
7.39
Zomedica Corp. stock logo
ZOMDF
Zomedica
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
N/A
Jushi Holdings Inc. stock logo
JUSHF
Jushi
21.68%
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
17.51%
Zomedica Corp. stock logo
ZOMDF
Zomedica
8.95%

Insider Ownership

CompanyInsider Ownership
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
31.30%
Jushi Holdings Inc. stock logo
JUSHF
Jushi
21.66%
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
1.34%
Zomedica Corp. stock logo
ZOMDF
Zomedica
5.58%
CompanyEmployeesShares OutstandingFree FloatOptionable
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
4064.95 million44.62 millionNot Optionable
Jushi Holdings Inc. stock logo
JUSHF
Jushi
1,234196.63 million154.04 millionNot Optionable
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
93.19 million3.15 millionNot Optionable
Zomedica Corp. stock logo
ZOMDF
Zomedica
50979.95 millionN/AN/A

Recent News About These Companies

Zomedica Corp. (ZOMDF)

New MarketBeat Followers Over Time

Media Sentiment Over Time

China Health Industries stock logo

China Health Industries OTCMKTS:CHHE

China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company operates through three segments: Humankind, HLJ Huimeijia, and Others. The company offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, hemp frozen age nourishing creams, hemp seed beers, and hemp seeds. It also provides health supplements, including Sailuozhi soft capsule, which is made from frog oil, soybean isoflavone, procyanidine, and vitamin E for freckle removal and skin moisture supplements under the QunLe brand; and propolis and black ant capsule that is made from propolis, black ant, acanthopanax, and astragalus root under the Kindlink brand. In addition, the company offers health products for acne removal, relieving eyestrain, enhancing bone density, enhancing memory, enhancing nutritional anemia and chloasma, relaxing bowels and promoting the discharge of lead, enhancing immunity and relieving physical fatigue, and dispelling chloasma, as well as iron and multivitamin, and mineral supplements. Further, it manufactures and sells various types of medical drugs, such as enema glycerini, umguentumacidi borici camphoratum, ge hong beriberi water, pelvic inflammation suppository, injury and paralysis tincture, indometacin and furazolidone suppositories, injury and rheumatism relieving paste, refining goupi cream, muskiness pain relieving paste, muskiness bone strengthener paste, matrine suppositories, ethacriding lactate solution, iodine tincture, mercurochrome solution, hydrogen peroxide solution, halcinonide cream, compound fluocinonide tincture, and policresulen vaginal suppository. The company primarily sells its products through sales personnel and sales agents. China Health Industries Holdings, Inc. was founded in 1996 and is based in Harbin City, the People's Republic of China.

Jushi stock logo

Jushi OTCMKTS:JUSHF

$0.29 -0.01 (-3.24%)
As of 06/27/2025 03:58 PM Eastern

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. It is also involved in the bulk wholesale of refined cannabinoids and terpenes. In addition, the company operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. The company is headquartered in Boca Raton, Florida.

vTv Therapeutics stock logo

vTv Therapeutics NASDAQ:VTVT

$14.49 -1.06 (-6.82%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$14.20 -0.29 (-1.97%)
As of 06/27/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

vTv Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and inflammatory diseases. The company's lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial for treating type 1 and type 2 diabetes; and TTP273, an orally available small molecule glucagon-like peptide 1 receptor agonists that is in Phase I clinical trial for the treatment of cystic fibrosis related diabetes, as well as in Phase II trial for the treatment of type 2 diabetes. It is also developing HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 inhibitor, which is in Phase III trial for the treatment of psoriasis, COPD, and atopic dermatitis, as well as TTP-RA, a RAGE antagonist for type 1 diabetes prevention. In addition, the company's other programs include HPP3033, a non-electrophilic therapeutic approach to activating the nuclear factor erythroid 2related factor 2 (Nrf2) pathway for the treatment of chronic diseases associated with oxidative stress; and Azeliragon, a RAGE antagonist for inflammatory lung diseases, including severe COVID-19, as well as for glioblastoma, other cancers, and cancer treatment-related conditions. vTv Therapeutics Inc. has license agreements with Reneo Pharmaceuticals, Inc. to develop and commercialize peroxisome proliferation activated receptor delta agonist program, including the compound HPP593 for therapeutic, prophylactic, and diagnostic application; and Anteris Bio, Inc. to develop and commercialize HPP971, a Nrf2 activator, as well as with Cantex Pharmaceuticals, Inc.; Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.; Newsoara Biopharma Co., Ltd.; JDRF International; and Novo Nordisk A/S. The company was incorporated in 2015 and is headquartered in High Point, North Carolina. vTv Therapeutics Inc. is a subsidiary of MacAndrews & Forbes Incorporated.

Zomedica stock logo

Zomedica OTC:ZOMDF

$0.04 0.00 (-0.74%)
As of 06/27/2025 03:57 PM Eastern

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.